IRIS Accounts Production v24.3.2.46 08655843 Board of Directors 1.10.22 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086558432022-09-30086558432024-03-31086558432022-10-012024-03-31086558432021-09-30086558432021-10-012022-09-30086558432022-09-3008655843ns15:EnglandWales2022-10-012024-03-3108655843ns14:PoundSterling2022-10-012024-03-3108655843ns10:Director12022-10-012024-03-3108655843ns10:PrivateLimitedCompanyLtd2022-10-012024-03-3108655843ns10:SmallEntities2022-10-012024-03-3108655843ns10:AuditExempt-NoAccountantsReport2022-10-012024-03-3108655843ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012024-03-3108655843ns10:SmallCompaniesRegimeForAccounts2022-10-012024-03-3108655843ns10:FullAccounts2022-10-012024-03-3108655843ns10:Director22022-10-012024-03-3108655843ns10:Director32022-10-012024-03-3108655843ns10:Director42022-10-012024-03-3108655843ns10:Director52022-10-012024-03-3108655843ns10:Director62022-10-012024-03-3108655843ns10:Director72022-10-012024-03-3108655843ns10:Director82022-10-012024-03-3108655843ns10:RegisteredOffice2022-10-012024-03-3108655843ns5:CurrentFinancialInstruments2024-03-3108655843ns5:CurrentFinancialInstruments2022-09-3008655843ns5:ShareCapital2024-03-3108655843ns5:ShareCapital2022-09-3008655843ns5:RetainedEarningsAccumulatedLosses2024-03-3108655843ns5:RetainedEarningsAccumulatedLosses2022-09-3008655843ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3108655843ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-30
REGISTERED NUMBER: 08655843 (England and Wales)















Unaudited Financial Statements

for the Period 1 October 2022 to 31 March 2024

for

S2S Health Limited

S2S Health Limited (Registered number: 08655843)






Contents of the Financial Statements
for the Period 1 October 2022 to 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


S2S Health Limited

Company Information
for the Period 1 October 2022 to 31 March 2024







DIRECTORS: Dr S S Sapre
Dr J Krecichwost
S S Sapre
Dr B Sapre
Mrs S S Sapre
Ms P Sapre
Dr T Sapre
Dr U Farooq





REGISTERED OFFICE: Seabright
6 Margaret Road
Crosby
Liverpool
L23 6TR





REGISTERED NUMBER: 08655843 (England and Wales)





ACCOUNTANTS: WR Accountants
Bank Chambers
31 The Square
Cumnock
Ayrshire
KA18 1AT

S2S Health Limited (Registered number: 08655843)

Balance Sheet
31 March 2024

31.3.24 30.9.22
Notes £    £   
CURRENT ASSETS
Debtors 4 1,339,025 1,414,132
Cash at bank 1,367,502 800,219
2,706,527 2,214,351
CREDITORS
Amounts falling due within one year 5 543,014 336,661
NET CURRENT ASSETS 2,163,513 1,877,690
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,163,513

1,877,690

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 2,163,413 1,877,590
SHAREHOLDERS' FUNDS 2,163,513 1,877,690

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 January 2025 and were signed on its behalf by:





Dr S S Sapre - Director


S2S Health Limited (Registered number: 08655843)

Notes to the Financial Statements
for the Period 1 October 2022 to 31 March 2024

1. STATUTORY INFORMATION

S2S Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


ACCOUNTING PERIOD
S2S Health Limited changed it's accounting reference date to 31 March and accordingly the accounts presented cover the period from 1 October 2022 to 31 March 2024.

COMPARATIVE AMOUNTS
Comparative amounts presented refer to the year ended 30 September 2022.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 23 (2022 - 23 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 30.9.22
£    £   
Other debtors 1,339,025 1,414,132

S2S Health Limited (Registered number: 08655843)

Notes to the Financial Statements - continued
for the Period 1 October 2022 to 31 March 2024

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 30.9.22
£    £   
Trade creditors 479 540
Taxation and social security 80,303 35,094
Other creditors 462,232 301,027
543,014 336,661

6. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

LOANS FROM DIRECTORS
All Directors loans are interest free and repayable on demand
31.3.2430.09.22
Dr S S Sapre Loan account£ £
At 1 October 202291,59791,957
Maximum amount due 91,59791,597
At 31 March 202490,80891,597

Mrs S Sapre
At 1 October 20227,9147,914
Maximum amount due7,9147,914
At 31 March 20247,3027,914

Dr J Krecichwost
At 1 October 20222,5602,560
Maximum amount due 2,5602,560
At 31 March 20242,5602,560

Dr B Sapre
At 1 October 20224,7624,762
Maximum amount due 7,3844,762
At 31 March 20247,3844,762


S2S Health Limited (Registered number: 08655843)

Notes to the Financial Statements - continued
for the Period 1 October 2022 to 31 March 2024

7. RELATED PARTY DISCLOSURES

Dr S S SAPRE PARTNERSHIP
Dr S Sapre, Mrs S Sapre, Dr J Krecichwost and Dr U Farooq are partners in Dr S&S Sapre Partnership
and Directors in S2S Health Limited.
The following transactions took place between S2S Health Limited and Dr S&S Sapre Partnership:

31.3.24
£
Due to S2S Health Limited at 1 October 202278,776
Management charge to S2S Health Limited(516,979)
Payments made to or for partnership295,618
Due (by) S2S Health Limited at 31 March 2024(142,585)


SEABRIGHT ENTERPRISES LIMITED
Dr S S Sapre and Mrs S Sapre are directors and shareholders of Seabright Enterprises Limited and directors and shareholders of S2S Health Limited..
The following transactions took place between S2S Health Limited and Seabright Enterprises Limited

31.3.2024
£
Due to S2S Health Limited at 1 October 2022 and 31 March 2024 1,335,356

8. ULTIMATE CONTROLLING PARTY

The controlling party is Dr S S Sapre.